Related references
Note: Only part of the references are listed.Advancing Cancer Treatment by Targeting Glutamine Metabolism-A Roadmap
Anna Halama et al.
CANCERS (2022)
Hyperpolarized [5-13C,4,4-2H2,5-15N]-L-glutamine provides a means of annotating in vivo metabolic utilization of glutamine
Roozbeh Eskandari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis
Kenji Ohshima et al.
METABOLITES (2021)
Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
Huan Xu et al.
METABOLITES (2021)
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer
Lingfan Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Vertebrate cell culture as an experimental approach - limitations and solutions
Mohammad Abbas et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY (2021)
ELOVL5-Mediated Long Chain Fatty Acid Elongation Contributes to Enzalutamide Resistance of Prostate Cancer
Huan Xu et al.
CANCERS (2021)
Metabolism in the tumor microenvironment: insights from single-cell analysis
Zhengtao Xiao et al.
ONCOIMMUNOLOGY (2020)
A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer
Manabu Kodama et al.
NATURE COMMUNICATIONS (2020)
Leucine regulates autophagy via acetylation of the mTORC1 component raptor
Sung Min Son et al.
NATURE COMMUNICATIONS (2020)
Metabolic Signaling Cascades Prompted by Glutaminolysis in Cancer
Raj Shah et al.
CANCERS (2020)
Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies
Zhefang Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Lipid Metabolism and Endocrine Resistance in Prostate Cancer, and New Opportunities for Therapy
Gergana E. Stoykova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Identification of Cancer-associated metabolic vulnerabilities by modeling multi-objective optimality in metabolism
Ziwei Dai et al.
CELL COMMUNICATION AND SIGNALING (2019)
Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer
Michael J. Lukey et al.
CELL REPORTS (2019)
N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway
Yu Yin et al.
MOLECULAR CANCER (2019)
Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia
Yuanyuan Wang et al.
NATURE COMMUNICATIONS (2019)
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
Yanjing Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A. Quigley et al.
CELL (2018)
Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State
Anneleen Daemen et al.
CELL METABOLISM (2018)
Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation
Vinicius Cruzat et al.
NUTRIENTS (2018)
Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism
Douglas E. Biancur et al.
NATURE COMMUNICATIONS (2017)
Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase
Jason R. Cantor et al.
CELL (2017)
Share Paper
